Sec. 806. GUIDANCE ON PATHOGEN-FOCUSED ANTIBACTERIAL DRUG DEVELOPMENT
157 words·~1 min read·
/statute-compilations/comps-9932/sec-806A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 806 GUIDANCE ON PATHOGEN-FOCUSED ANTIBACTERIAL DRUG DEVELOPMENT **[**[21 U.S.C. 355 note](/us/usc/t21/s355)**]** ###
(a)Draft Guidance Not later than June 30, 2013, in order to facilitate the development of antibacterial drugs for serious or life-threatening bacterial infections, particularly in areas of unmet need, the Secretary of Health and Human Services shall publish draft guidance that— ####
(1)specifies how preclinical and clinical data can be utilized to inform an efficient and streamlined pathogen-focused antibacterial drug development program that meets the approval standards of the Food and Drug Administration; and ####
(2)provides advice on approaches for the development of antibacterial drugs that target a more limited spectrum of pathogens. ###
(b)Final Guidance Not later than December 31, 2014, after notice and opportunity for public comment on the draft guidance under subsection (a), the Secretary of Health and Human Services shall publish final guidance consistent with this section. # TITLE IX DRUG APPROVAL AND PATIENT ACCESS
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 806
GUIDANCE ON PATHOGEN-FOCUSED ANTIBACTERIAL DRUG DEVELOPMENT
Cites 1Cited by 0 across 0 sources